Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Generation of a stable anti-human CD44v6 scFv and analysis of its cancer-targeting ability in vitro

12 Mar 2010

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Glycosylation and Glycoproteins Research
Share to Immunotherapy and Immune Responses
Share to Monoclonal and Polyclonal Antibodies Research

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 20224978
DOI: 10.1007/s00262-010-0819-z

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Generation of a stable anti-human CD44v6 scFv and analysis of its cancer-targeting ability in vitroPMID 20224978Read ↗

Anti-tumor effect against human cancer xenografts by a fully human monoclonal antibody to a variant 8-epitope of CD44R1 expressed on cancer stem cells.Semantic proximity Read ↗

CD44 and its implication in neoplastic diseasesSemantic proximity Read ↗

Development of a Novel Anti-CD44 variant 6 Monoclonal Antibody for Multiple Applications against Colorectal CarcinomasSemantic proximity Read ↗

Development of a Novel Anti-CD44 Variant 5 Monoclonal Antibody C<sub>44</sub>Mab-3 for Multiple Applications against Pancreatic CarcinomasSemantic proximity Read ↗

Development of a MET-targeted single-chain antibody fragment as an anti-oncogene targeted therapy for breast cancerSemantic proximity Read ↗

A human monoclonal antibody 264RAD targeting αvβ6 integrin reduces tumour growth and metastasis, and modulates key biomarkers in vivoSemantic proximity Read ↗

WITHDRAWN: High-throughput preclinical screening of CD123 scFv to design 3rd generation of CAR T-cell in the treatment of BPDCN patientSemantic proximity Read ↗

Development of unique cytotoxic chimeric antigen receptors based on human scFv targeting B7H6.Semantic proximity Read ↗

Dual transgenesis of T cells with a CD44v6-specific chimeric antigen receptor and a suicide gene for the safe eradication of chemoresistant leukaemia and myelomaSemantic proximity Read ↗

CD44 variant 6 is associated with prostate cancer growth and chemo-/radiotherapy response in vivo.Semantic proximity Read ↗

A Novel Anti-CD44 Variant 9 Monoclonal Antibody C<sub>44</sub>Mab-1 was Developed for Immunohistochemical Analyses Against Colorectal CancersSemantic proximity Read ↗

Development of a Novel Anti-CD44 Variant 8 Monoclonal Antibody C<sub>44</sub>Mab-94 against Gastric CarcinomasSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.